Beijing Tiantan Biological Products Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 704.84 million compared to CNY 847.14 million a year ago. Revenue was CNY 704.84 million compared to CNY 847.14 million a year ago. Net income was CNY 125.18 million compared to CNY 151.72 million a year ago. Basic earnings per share from continuing operations was CNY 0.075 compared to CNY 0.1 a year ago. Diluted earnings per share from continuing operations was CNY 0.075 compared to CNY 0.1 a year ago.